• 1. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 2. An alternative biorefinery approach to address microalgal seasonality: blending with spent coffee grounds
  Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
• 3. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 4. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156
• 5. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782

Chemical Profile of 1,3-Dimethyl-5-nitropyrimidine-2,4(1H,3H)-dione (CAS No. 41613-26-7)

1,3-Dimethyl-5-nitropyrimidine-2,4(1H,3H)-dione, identified by its Chemical Abstracts Service (CAS) number 41613-26-7, is a significant heterocyclic compound that has garnered considerable attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the nitropyrimidine class, a subclass of pyrimidine derivatives characterized by the presence of a nitro group at the 5-position of the pyrimidine ring. The structural motif of 1,3-Dimethyl-5-nitropyrimidine-2,4(1H,3H)-dione incorporates two carbonyl groups at the 2 and 4 positions, forming a dione structure, which contributes to its unique reactivity and potential applications in synthetic chemistry.

The molecular formula of this compound is C?H?N?O?, reflecting its composition of carbon, hydrogen, nitrogen, and oxygen atoms. The nitro group (–NO?) at the 5-position is a key functional moiety that influences the electronic properties and reactivity of the molecule. The presence of two methyl groups at the 1 and 3 positions enhances the stability of the pyrimidine ring while also affecting its interaction with biological targets. This combination of structural features makes 1,3-Dimethyl-5-nitropyrimidine-2,4(1H,3H)-dione a versatile intermediate in the synthesis of more complex pharmacophores.

In recent years, there has been growing interest in nitropyrimidine derivatives due to their potential as bioactive molecules. Research has demonstrated that these compounds can exhibit a wide range of biological activities, including antimicrobial, antiviral, anti-inflammatory, and anticancer properties. The nitro group in particular plays a crucial role in modulating these activities by serving as a site for redox transformations or by directly interacting with biological targets. The dione moiety further contributes to the compound's reactivity, allowing for further functionalization through nucleophilic addition or condensation reactions.

One of the most compelling aspects of 1,3-Dimethyl-5-nitropyrimidine-2,4(1H,3H)-dione is its utility as a building block in drug discovery. Its rigid pyrimidine core provides a scaffold that can be modified to target specific biological pathways. For instance, studies have shown that nitropyrimidines can inhibit enzymes involved in DNA replication and repair, making them promising candidates for developing treatments against various cancers. Additionally, the ability to introduce different substituents at strategic positions on the pyrimidine ring allows researchers to fine-tune the pharmacokinetic and pharmacodynamic properties of derived compounds.

The synthesis of 1,3-Dimethyl-5-nitropyrimidine-2,4(1H,3H)-dione typically involves multi-step organic transformations starting from readily available precursors. A common synthetic route includes the nitration of a substituted pyrimidine followed by cyclization or oxidation steps to introduce the dione functionality. Advances in synthetic methodologies have enabled more efficient and scalable production processes for this compound, facilitating its use in both academic research and industrial applications.

Recent advancements in computational chemistry have also enhanced our understanding of how 1,3-Dimethyl-5-nitropyrimidine-2,4(1H,3H)-dione interacts with biological targets. Molecular docking studies have identified potential binding pockets on proteins relevant to diseases such as cancer and inflammation. These insights have guided the design of novel derivatives with improved binding affinities and selectivity. Furthermore, computational modeling has been used to predict metabolic pathways and potential side effects associated with this compound and its derivatives.

The pharmaceutical industry has taken note of these findings and is actively exploring 1,3-Dimethyl-5-nitropyrimidine-2,4(1H,3H)-dione as a lead compound for new drug candidates. Preclinical studies have demonstrated promising results in animal models for several therapeutic indications. While human clinical trials are still in progress for some derivatives derived from this compound, their preclinical efficacy suggests that they could offer significant therapeutic benefits once further developed.

Another area where 1,3-Dimethyl-5-nitropyrimidine-2,4(1H,3H)-dione shows promise is in material science applications beyond pharmaceuticals. The unique electronic properties conferred by its nitro group make it an interesting candidate for use in organic electronics or as a precursor for advanced materials with specialized functions such as light-emitting diodes (LEDs) or photovoltaic cells.

In conclusion, 1,3-Dimethyl-5-nitropyrimidine-2,4(1H,3H)-dione (CAS No. 41613-26-7) is a multifaceted compound with significant potential across multiple disciplines including medicinal chemistry, drug discovery, and materials science.The combination of structural features such as its nitro group, dione moiety, and methyl substituents endows it with unique reactivity and biological activity.

• 28495-88-7(1-methyl-5-nitro-1,2,3,4-tetrahydropyrimidine-2,4-dione)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)